Mainz Biomed B.V. (MYNZ)
Mainz Biomed B.V. Statistics
Share Statistics
Mainz Biomed B.V. has 3.04M shares outstanding. The number of shares has increased by -89.85% in one year.
| Shares Outstanding | 3.04M |
| Shares Change (YoY) | -89.85% |
| Shares Change (QoQ) | 10.94% |
| Owned by Institutions (%) | 1.03% |
| Shares Floating | 2.89M |
| Failed to Deliver (FTD) Shares | 8.35K |
| FTD / Avg. Volume | 3.84% |
Short Selling Information
The latest short interest is 79.74K, so 2.62% of the outstanding shares have been sold short.
| Short Interest | 79.74K |
| Short % of Shares Out | 2.62% |
| Short % of Float | 2.76% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -0.19 and the forward PE ratio is -1.78. Mainz Biomed B.V.'s PEG ratio is 0.
| PE Ratio | -0.19 |
| Forward PE | -1.78 |
| PS Ratio | 4.68 |
| Forward PS | 0.3 |
| PB Ratio | 0.69 |
| P/FCF Ratio | -0.24 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Mainz Biomed B.V..
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.32, with a Debt / Equity ratio of 0.54.
| Current Ratio | 1.32 |
| Quick Ratio | 1.26 |
| Debt / Equity | 0.54 |
| Debt / EBITDA | -0.17 |
| Debt / FCF | -0.19 |
| Interest Coverage | -17.39 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $47.05K |
| Profits Per Employee | $-1.14M |
| Employee Count | 19 |
| Asset Turnover | 0.07 |
| Inventory Turnover | 0.86 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -91.24% in the last 52 weeks. The beta is 0.53, so Mainz Biomed B.V.'s price volatility has been higher than the market average.
| Beta | 0.53 |
| 52-Week Price Change | -91.24% |
| 50-Day Moving Average | 4.93 |
| 200-Day Moving Average | 9.08 |
| Relative Strength Index (RSI) | 40.93 |
| Average Volume (20 Days) | 217.52K |
Income Statement
In the last 12 months, Mainz Biomed B.V. had revenue of 893.99K and earned -21.65M in profits. Earnings per share was -22.36.
| Revenue | 893.99K |
| Gross Profit | 574.88K |
| Operating Income | -18.7M |
| Net Income | -21.65M |
| EBITDA | -19.56M |
| EBIT | -20.58M |
| Earnings Per Share (EPS) | -22.36 |
Balance Sheet
The company has 6.24M in cash and 3.27M in debt, giving a net cash position of 2.96M.
| Cash & Cash Equivalents | 6.24M |
| Total Debt | 3.27M |
| Net Cash | 2.96M |
| Retained Earnings | -90.98M |
| Total Assets | 13.24M |
| Working Capital | 1.89M |
Cash Flow
In the last 12 months, operating cash flow was -17.09M and capital expenditures -254.95K, giving a free cash flow of -17.34M.
| Operating Cash Flow | -17.09M |
| Capital Expenditures | -254.95K |
| Free Cash Flow | -17.34M |
| FCF Per Share | -17.91 |
Margins
Gross margin is 64.31%, with operating and profit margins of -2091.23% and -2421.8%.
| Gross Margin | 64.31% |
| Operating Margin | -2091.23% |
| Pretax Margin | -2421.8% |
| Profit Margin | -2421.8% |
| EBITDA Margin | -2187.76% |
| EBIT Margin | -2091.23% |
| FCF Margin | -1940.17% |
Dividends & Yields
MYNZ does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for MYNZ is $14, which is 319.2% higher than the current price. The consensus rating is "Hold".
| Price Target | $14 |
| Price Target Difference | 319.2% |
| Analyst Consensus | Hold |
| Analyst Count | 2 |
Stock Splits
The last stock split was on Dec 3, 2024. It was a backward split with a ratio of 1:40.
| Last Split Date | Dec 3, 2024 |
| Split Type | backward |
| Split Ratio | 1:40 |
Scores
| Altman Z-Score | -18.5 |
| Piotroski F-Score | 4 |